Literature DB >> 1403703

A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues.

J Fassberg1, V J Stella.   

Abstract

Quantitative rate and equilibrium constants for the hydrolysis of the lactone (ring E) in camptothecin (1) and analogues (2-5, all substituted in the A ring of 1) at 25 degrees C in aqueous solution were determined by high-performance liquid chromatography with UV-visible detection and by UV-visible spectrophotometry. It was shown that the lactone was converted to the carboxylate in a pH-dependent equilibrium. No major differences were observed in rate and equilibrium constants for 1-5, a result suggesting that the mechanism of lactone hydrolysis is independent of a variety of substituents on the A ring. The conversion of the lactone to its carboxylate form occurred under neutral and basic conditions and appeared to be largely dependent on hydroxide ion. The conversion of the carboxylate to the lactone was observed under neutral and acidic conditions and was pH independent at pH values greater than 5 and dependent on hydronium ion at pH values less than 5. Significant incorporation of oxygen-18 into the lactone ring of 3, a water-soluble analogue of 1, was observed for the ring opening and subsequent ring closing of 3 in H2(18)O. This finding strongly suggests that the mechanism of lactone ring hydrolysis involved acyl cleavage rather than alkyl cleavage. Kinetic solvent isotope effects (kH2O/kD2O, where kH2O and kD2O are the rate constants in H2O and D2O, respectively), obtained over the pH-rate profile for 1, were used to speculate about the nature of the transition states involved in the opening and closing reactions of the lactone ring.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403703     DOI: 10.1002/jps.2600810718

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  60 in total

1.  Comparative molecular field analysis and molecular modeling studies of 20-(S)-camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer/antitumor agents.

Authors:  S W Carrigan; P C Fox; M E Wall; M C Wani; J P Bowen
Journal:  J Comput Aided Mol Des       Date:  1997-01       Impact factor: 3.686

2.  Pharmacokinetic modeling to assess factors affecting the oral bioavailability of the lactone and carboxylate forms of the lipophilic camptothecin analogue AR-67 in rats.

Authors:  Eyob D Adane; Zhiwei Liu; Tian-Xiang Xiang; Bradley D Anderson; Markos Leggas
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

3.  Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.

Authors:  Vijay Joguparthi; Shaoxin Feng; Bradley D Anderson
Journal:  Int J Pharm       Date:  2007-10-12       Impact factor: 5.875

4.  Design and synthesis of novel spin-labeled camptothecin derivatives as potent cytotoxic agents.

Authors:  Xiao-Bo Zhao; Dan Wu; Mei-Juan Wang; Masuo Goto; Susan L Morris-Natschke; Ying-Qian Liu; Xiao-Bing Wu; Zi-Long Song; Gao-Xiang Zhu; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2014-09-28       Impact factor: 3.641

5.  Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma.

Authors:  Eric M Mastria; Mingnan Chen; Jonathan R McDaniel; Xinghai Li; Jinho Hyun; Mark W Dewhirst; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2015-01-28       Impact factor: 9.776

6.  Stable supersaturated aqueous solutions of silatecan 7-t-butyldimethylsilyl-10-hydroxycamptothecin via chemical conversion in the presence of a chemically modified beta-cyclodextrin.

Authors:  Tian-Xiang Xiang; Bradley D Anderson
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

7.  Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.

Authors:  Katayoun Derakhshandeh; Marzieh Soheili; Simin Dadashzadeh; Reza Saghiri
Journal:  Int J Nanomedicine       Date:  2010-08-09

8.  Physicochemical characterization of 9-aminocamptothecin in aqueous solutions.

Authors:  Shahidur Rahman; Deval Patel; Michalakis Savva
Journal:  AAPS PharmSciTech       Date:  2013-12-03       Impact factor: 3.246

9.  Plasma pharmacokinetics of lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats.

Authors:  D O Scott; D S Bindra; V J Stella
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

Review 10.  Clinical pharmacokinetics of topotecan.

Authors:  V M Herben; W W ten Bokkel Huinink; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.